Related Experiment Video
Updated: Jun 14, 2026
Tissue Engineering: Construction of a Multicellular 3D Scaffold for the Delivery of Layered Cell Sheets
Published on: October 3, 2014
Synthetic scaffolds functionalized with mesenchymal stem/stromal cells-derived extracellular matrix for bone tissue
Margarida F Domingues1,2, Marta S Carvalho1,2, Paola Sanjuan-Alberte1,2
1Department of Bioengineering and iBB - Institute for Bioengineering and Biosciences, Instituto Superior Técnico, Universidade de Lisboa Av. Rovisco Pais Lisboa 1049-001 Portugal joao.f.da.silva@tecnico.ulisboa.pt.
Mesenchymal stem cell-derived decellularized extracellular matrix (dECM) composites show promise for bone tissue engineering. Combining dECM with scaffolds enhances bone regeneration, addressing limitations of current bone graft strategies.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Tissue Engineering
Background:
- Bone injuries are a global health concern, especially for aging populations, often requiring surgical intervention due to incomplete regeneration.
- Autologous bone grafts are standard but face limitations like donor scarcity and donor site morbidity.
- Bone tissue engineering (BTE) offers an alternative using biomaterials, cells, and growth factors.
Purpose of the Study:
- To review the potential of mesenchymal stem/stromal cell-derived decellularized extracellular matrix (MSC-dECM) composite scaffolds for BTE.
- To explore various scaffold types incorporating MSC-dECM and their impact on bone regeneration.
- To identify current challenges and future directions for clinical translation of MSC-dECM scaffolds.
Main Methods:
- Review of literature on MSC-dECM composite scaffolds for BTE.
- Exploration of different scaffold formats: 3D printed constructs, electrospun matrices, hydrogels, and metallic scaffolds.
- Analysis of how MSC-dECM incorporation influences osteoconductivity and osteoinductivity.
Main Results:
- MSC-dECM closely mimics native bone extracellular matrix (ECM) and provides beneficial molecules for regeneration.
- Incorporation of MSC-dECM into various scaffolds enhances osteogenic marker expression and calcium deposition in vitro.
- MSC-dECM composite scaffolds demonstrate improved bone formation in vivo compared to scaffolds without dECM.
Conclusions:
- MSC-dECM composite scaffolds represent a promising strategy for enhancing bone regeneration in BTE.
- These scaffolds improve osteoconductive and osteoinductive properties, leading to better bone formation.
- Further research is needed to scale up MSC-dECM production and refine patient-specific applications for clinical success.
